Beta Bionics (BBNX) EBIAT (2024 - 2025)
Beta Bionics (BBNX) has disclosed EBIAT for 2 consecutive years, with -$13.5 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 25.64% to -$13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$73.2 million through Dec 2025, down 33.68% year-over-year, with the annual reading at -$73.2 million for FY2025, 33.68% down from the prior year.
- EBIAT hit -$13.5 million in Q4 2025 for Beta Bionics, up from -$14.2 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$9.7 million in Q3 2024 to a low of -$28.7 million in Q1 2025.